NCT00985166View on ClinicalTrials.gov

A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)

PHASE3CompletedINTERVENTIONAL
Enrollment

801

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

May 31, 2002

Study Completion Date

May 31, 2003

Conditions
MeaslesMumpsRubellaVaricella
Interventions
BIOLOGICAL

ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live)

A Single 0.5 mL subcutaneous injection at Day 1

BIOLOGICAL

Comparator: M-M-R II

A Single 0.5 mL subcutaneous injection at Day 1

BIOLOGICAL

Comparator: Varivax

A Single 0.5 mL subcutaneous injection at Day 1

BIOLOGICAL

Comparator: Placebo

A Single 0.5 mL subcutaneous placebo injection at Day 1

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00985166 - A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) | Biotech Hunter | Biotech Hunter